Our flexible workspace model reduces energy consumption, and we are committed to further minimizing our carbon footprint. From adopting energy-efficient infrastructure to reducing travel emissions, we strive for a cleaner, healthier future.

Our portfolio companies prioritize environmental sustainability, from green chemistry in biotech to sustainable sourcing in nutraceuticals. We ensure our products not only improve human health but also protect the planet.

We have a diverse, multinational team that brings together a wealth of knowledge and creativity to organization. In our endeavor to further enrich the diversity within our organization, we actively foster an inclusive environment where different perspectives and experiences fuel innovation.

Each company in our portfolio addresses unmet healthcare needs, aiming to enhance quality of life. From rare disease treatments to next-generation medical devices, Cube Labs strives for a more accessible and equitable healthcare system.

Our governance framework comprises a Board of Directors, a Board of Statutory Auditors, and a Shareholders’ General Meeting, all guided by the Corporate Governance Code for listed companies.

Our commitment to innovation presents two key ethical challenges. First, ethical fundraising requires collaboration with investors who share our values and mission. Second, we must balance our focus between emerging and primary markets. While primary markets offer quicker financial returns, emerging markets, though less immediately profitable, are critical for delivering innovative healthcare solutions with the most significant impact. Striking this balance is essential to our strategy and our commitment to advancing healthcare equity.